| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;95:489-496.)
© 1997 American Heart Association, Inc.
Articles |
Nitric Oxide Contributes to the Progression of Myocardial Damage in Experimental Autoimmune Myocarditis in Rats
the Second Department of Medicine (S.I., M.H., S.A., T.S., H.I., F.M.), Tokyo Medical and Dental University, Tokyo; Departments of Pathology (S.I., T.N., T.K.) and Kidney Surgery (S.O.), Tokyo Women's Medical College, Tokyo; Second Department of Medicine (K.Y., M.M.), Yamaguchi University, Yamaguchi; and Second Department of Physiology (M.U.M., H.N.), Tokai University, Tokai, Japan.
Correspondence to Michiaki Hiroe, MD, Cardiology Division, Second Department of Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan.
Background Excess amounts of NO produced by an inducible NO synthase (iNOS) in response to cytokines may be cytotoxic and can be destructive to tissue. We investigated the role of NO in the development of myocardial damage and the effects of aminoguanidine (AG), an inhibitor of iNOS, on experimental autoimmune myocarditis in rats.
Methods and Results Autoimmune myocarditis was induced in 20 Lewis rats by injection of porcine cardiac myosin. Ten of the 20 rats were administered AG. The severity of myocarditis was evaluated by measuring the size of myocarditic lesion and serum levels of CK-MB. Serum NO levels were determined using the Cd/Cu method. Tissue specimens were immunohistochemically examined for iNOS and nitrotyrosine. Histopathological study revealed extensive myocardial destruction and massive inflammatory cell infiltration in AG-untreated rats but only focal mononuclear cell infiltration in AG-treated rats. The mean percent areas of inflammatory lesions in the untreated and treated rats were 56±13% and 3±2%, respectively (P<.001). NO levels were 102±23 and 25±9 IU/L, respectively (P<.01). CK-MB levels were 68±13 and 16±13 nmol/L, respectively (P<.01). Superoxide production as measured with an ex vivo monitoring system was also significantly decreased in the treated rats. Nitrotyrosine relating to the generation of peroxynitrite was detected through immunostaining in the inflammatory lesions of untreated rats but not in those of treated rats.
Conclusions Excess amounts of NO produced by iNOS appear to contribute to the progression of myocardial damage in myocarditis. AG may prove to be useful in the treatment of myocarditis.
Key Words: free radicals • myocarditis • myosin • nitric oxide • inducible nitric oxide synthase
This article has been cited by other articles:
 |
|
 |
|
  M. Nimata, T.-a. Okabe, M. Hattori, Z. Yuan, K. Shioji, and C. Kishimoto MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2514 - H2518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M Bell, H. L Maddock, and D. M Yellon The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart Cardiovasc Res, February 1, 2003; 57(2): 405 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. V. Turko and F. Murad Protein Nitration in Cardiovascular Diseases Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Predescu, S. Predescu, and A. B. Malik Transport of nitrated albumin across continuous vascular endothelium PNAS, October 15, 2002; 99(21): 13932 - 13937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Saito, F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H339 - H345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wang, G. Sawicki, and R. Schulz Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2 Cardiovasc Res, January 1, 2002; 53(1): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Holleyman and D. F Larson Apoptosis in the ischemic reperfused myocardium Perfusion, December 1, 2001; 16(6): 491 - 502. [Abstract] [PDF]
|
|
|
|
 |
|
 M.-S. Zhou, A. Adam, and L. Raij Review: Interaction among angiotensin II, nitric oxide and oxidative stress Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S59 - S63. [PDF]
|
|
|
|
 |
|
 P. Ferdinandy and R. Schulz Peroxynitrite: Toxic or Protective in the Heart? Circ. Res., February 2, 2001; 88 (2): e12 - e13. [Full Text] [PDF]
|
|
|
|
 |
|
 M T Kearney, J M Cotton, P J Richardson, and A M Shah Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management Postgrad. Med. J., January 1, 2001; 77(903): 4 - 10. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. S. Machado, G. A. Martins, J. C. S. Aliberti, F. L. A. C. Mestriner, F. Q. Cunha, and J. S. Silva Trypanosoma cruzi-Infected Cardiomyocytes Produce Chemokines and Cytokines That Trigger Potent Nitric Oxide-Dependent Trypanocidal Activity Circulation, December 12, 2000; 102(24): 3003 - 3008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ferdinandy, H. Danial, I. Ambrus, R. A. Rothery, and R. Schulz Peroxynitrite Is a Major Contributor to Cytokine-Induced Myocardial Contractile Failure Circ. Res., August 4, 2000; 87(3): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Song, X. Lu, and Q. Feng Tumor necrosis factor-{alpha} induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes Cardiovasc Res, February 1, 2000; 45(3): 595 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Shah Inducible nitric oxide synthase and cardiovascular disease Cardiovasc Res, January 1, 2000; 45(1): 148 - 155. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovasc Res, August 15, 1999; 43(3): 698 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ishiyama, M. Hiroe, T. Nishikawa, T. Shimojo, T. Hosokawa, I. Ikeda, T. Toyozaki, T. Kasajima, and F. Marumo Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats Cardiovasc Res, August 1, 1999; 43(2): 389 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iwasaki, A. Matsumori, T. Yamada, T. Shioi, W. Wang, K. Ono, R. Nishio, M. Okada, and S. Sasayama Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1400 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kawai From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future Circulation, March 2, 1999; 99(8): 1091 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Depre, X. Havaux, J. Renkin, J. L. J. Vanoverschelde, and W. Wijns Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque Cardiovasc Res, February 1, 1999; 41(2): 465 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ishiyama, M. Hiroe, T. Nishikawa, T. Shimojo, S. Abe, H. Fujisaki, H. Ito, K. Yamakawa, N. Kobayashi, T. Kasajima, et al. The Fas/Fas Ligand System Is Involved in the Pathogenesis of Autoimmune Myocarditis in Rats J. Immunol., November 1, 1998; 161(9): 4695 - 4701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Akiyama, A. Kimura, H. Suzuki, Y. Takeyama, T. L. Gluckman, A. Terhakopian, T. Katagiri, K.-Y. Suh, J. Roseto, and R. J. Bing Production of oxidative products of nitric oxide in infarcted human heart J. Am. Coll. Cardiol., August 1, 1998; 32(2): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukuchi, S. N. A. Hussain, and A. Giaid Heterogeneous Expression and Activity of Endothelial and Inducible Nitric Oxide Synthases in End-Stage Human Heart Failure : Their Relation to Lesion Site and ß-Adrenergic Receptor Therapy Circulation, July 14, 1998; 98(2): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A Doggrell and L. Brown Rat models of hypertension, cardiac hypertrophy and failure Cardiovasc Res, July 1, 1998; 39(1): 89 - 105. [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Meldrum Tumor necrosis factor in the heart Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R577 - R595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft Circulation, November 18, 1997; 96(10): 3436 - 3442. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mikami, S. Kawashima, K. Kanazawa, K.-i. Hirata, H. Hotta, Y. Hayashi, H. Itoh, and M. Yokoyama Low-Dose N{omega}-Nitro-L-Arginine Methyl Ester Treatment Improves Survival Rate and Decreases Myocardial Injury in a Murine Model of Viral Myocarditis Induced by Coxsackievirus B3 Circ. Res., October 19, 1997; 81(4): 504 - 511. [Abstract] [Full Text]
|
|
|
|
|
|
O. Yokoseki, J.-i. Suzuki, H. Kitabayashi, N. Watanabe, Y. Wada, M. Aoki, R. Morishita, Y. Kaneda, T. Ogihara, H. Futamatsu, et al. cis Element Decoy Against Nuclear Factor-{kappa}B Attenuates Development of Experimental Autoimmune Myocarditis in Rats Circ. Res., November 9, 2001; 89(10): 899 - 906. [Abstract] [Full Text] [PDF]
|
|